Divalproex Sodium Market

Divalproex Sodium Market - Size,
Share, Outlook, and Opportunity
Analysis, 2018 - 2026
Divalproex Sodium Market, by Dosage Form (Capsule, Tablet, and
Syrup), by Application (Epilepsy, Manic Depressive Illness, and Other),
by Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and
Online Pharmacies), and by Region (North America, Latin America,
Europe, Asia Pacific, Middle East, and Africa) - Size, Share, Outlook, and
Opportunity Analysis 2018 - 2026
Divalproex sodium is a Food and Drug Administrator (FDA) approved anti-epileptic drug used to
treat migraine headaches, manic episodes of bipolar disorders, and certain types of seizures.
Divalproex sodium is known for its anticonvulsant properties for the treatment of epilepsy.
Divalproex sodium comes under three dosage forms: capsule, tablet, and syrup. Divalproex
sodium oral tablet is available in brand-names, Depakote ER and Depakote. Divalproex sodium is
also used in various combinational therapies.
The recommended initial dosage of Depakote for the treatment of bipolar disorders is 750 mg
daily, whereas for complex partial seizures, initial dosage starts with 10 to 15 mg/kg/day. Also,
recommended starting dose for migraine headache is 250 mg twice daily to achieve therapeutic
response. For instance, according to study published in JAMA Psychiatry Journal 2012, in a
combined sample of 61,392 adults from 11 countries, the total lifetime prevalence of bipolar
disorder-I was 0.6%, and 0.4% for bipolar disorder-II and subthreshold bipolar disorder was 1.4%,
yielding a total prevalence estimates bipolar disorder spectrum of 2.4% globally.
Request Sample Copy of this Business Report @
https://www.coherentmarketinsights.com/insight/request-sample/1315
Moreover, rising patient pool around the world affected with epilepsy and migraine headaches is
also expected to boost demand for divalproex sodium market significantly. For instance,
according to the World Health Organization 2018 key facts, around 50 million people were
globally affected with epilepsy, making it one of the most common neurological disease, and
around 80% of the people with epilepsy live in low- and middle-income countries. According to
The Migraine Trust Facts and Figures estimates, the global prevalence of migraine was 14.7% for
year 2013, that’s around 1 in 7 people. Furthermore, increasing awareness regarding diseases

and various government initiatives to prevent head migraine is expected to propel growth of
divalproex sodium market size.
For instance, In 2011 The National Quality Strategy (NQS) was launched as the national strategy
for quality improvement in health care, This was led by Agency for Healthcare Research and
Quality on behalf of the U.S. Department of Health and Human Services (HHS). However,
introduction of generic products by market giants in the region is expected to hamper the market
growth in the region. For instance, in 2008, Mylan launched generic of Abbott's Depakote ER in
the U.S.
Asia Pacific is expected to show significant growth followed by Europe, owing to increased
prevalence of epilepsy and head migraine among the population in the region. For instance,
according to study published in the Journal of Global Health 2017, showed that lifetime epilepsy
prevalence was 1.99% in 1990 and 7.15% in 2015 among the Chinese population.
Browse More About the Keyword Market Study @
https://www.coherentmarketinsights.com/ongoing-insight/divalproex-sodium-market-1913
Report includes chapters which deeply display the following deliverable about industry:
• Divalproex Sodium Market Research Objective and Assumption
• Divalproex Sodium Market Purview - Report Description, Executive Summary, and Coherent
Opportunity Map (COM)
• Divalproex Sodium Market Dynamics, Regulations, and Trends Analysis - Market Dynamics,
Regulatory Scenario, Industry Trend, Merger and Acquisitions, New system Launch/Approvals, Value
Chain Analysis, Porter’s Analysis, and PEST Analysis
• Global Divalproex Sodium Market, By Regions
• Divalproex Sodium Market Competition by Manufacturers including Production, Share, Revenue,
Average Price, Manufacturing Base Distribution, Sales Area and Product Type.
• Divalproex Sodium Market Manufacturers Profiles/Analysis including Company Basic Information,
Manufacturing Base and Its Competitors.
• Divalproex Sodium Market Manufacturing Cost Analysis including Key Raw Materials and Key
Suppliers of Raw Materials.
• Industrial Chain, Sourcing Strategy and Downstream Buyers including Upstream Raw Materials
Sourcing and Downstream Buyers
• Marketing Strategy Analysis, Distributors/Traders including Marketing Channel, Market Positioning
and Distributors/Traders List.
• Market Effect Factors Analysis including Technology Progress/Risk, Consumer Needs/Customer
Preference Change and Economic/Political Environmental Change.
• Divalproex Sodium Market Forecast including Production, Consumption, Import and Export Forecast
by Type, Applications and Region.
• Research Findings and Conclusion
Table of Contents of Keyword Market Report:
1. Research Objective and assumption

2. Market Purview
3. Market Dynamics, Regulations, and Trends Analysis
4. Keyword Market, By Advanced Water Meters, 2017 - 2025 (USD Million)
5. Keyword Market, By Service, 2017 - 2025 (USD Million)
6. Keyword Market, By Solution, 2017 - 2025 (USD Million)
7. Keyword Market, By Regions, 2017 - 2025 (USD Million)
8. Competitive Landscape
Ask for Discount before Buying @
https://www.coherentmarketinsights.com/insight/request-discount/1913
About Coherent Market Insights:
Coherent Market Insights is a prominent market research and consulting firm offering action-ready
syndicated research reports, custom market analysis, consulting services, and competitive analysis
through various recommendations related to emerging market trends, technologies, and potential
absolute dollar opportunity.
Contact Us:
Mr. Shah
Coherent Market Insights
1001 4th Ave,
#3200
Seattle, WA 98154
Tel: +1-206-701-6702
Email: sales@coherentmarketinsights.com